Sign in
4

Changes in Ownership

Upstream Bio, Inc. Filed Acc 0000950170-25-016466

Options or other derivatives

  • Chief Medical Officer acquired 165,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Deykin Aaron Chief Medical Officer 2025-02-06 Grant or award · Stock Option (Right to Buy) +165,000 165,000 D
Loading xslF345X05/ownership.xml…